1-18 of 18
Jacques Galipeau
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 3418: IL6/1 fusion cytokine as a novel adjuvant for manufacturing of T cells for the treatment of ovarian cancer

Sejal Tarun Sharma, Rahul Das, Lisa Barroilhet, Manish Patankar, Jacques Galipeau
Journal: Cancer Research
Cancer Res (2025) 85 (8_Supplement_1): 3418.
https://doi.org/10.1158/1538-7445.AM2025-3418
Published: 21 April 2025
View articletitled, Abstract 3418: IL6/1 fusion cytokine as a novel adjuvant for manufacturing of T cells for the treatment of ovarian cancer
Journal Articles

Abstract 3152: IFN-gamma stimulated cryopreserved mesenchymal stromal cells for treatment of radiation induced xerostomia

Cristina Paz, Grace Blitzer, Annemarie Glassey, Kwangok P. Nickel, Jayeeta Giri, Andrea Pennati, Daniel Robbins, Tadeas Lunga, Susan Thibeault, Jacques Galipeau, Randall Kimple
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 3152.
https://doi.org/10.1158/1538-7445.AM2022-3152
Published: 15 June 2022
View articletitled, Abstract 3152: IFN-gamma stimulated cryopreserved mesenchymal stromal cells for treatment of radiation induced xerostomia
Journal Articles

Abstract 2845: Synthetic fusion cytokine, GIFT4, transduced autologous peritoneal immune cells - a novel cell therapy for the treatment of ovarian cancer

Sejal Tarun Sharma, Pradyut Paul, Rahul Das, Shala Yuan, Lisa Barroilhet, Jessica Vazquez, Aleksandar K. Stanic, Jacques Galipeau, Manish Patankar
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 2845.
https://doi.org/10.1158/1538-7445.AM2022-2845
Published: 15 June 2022
View articletitled, Abstract 2845: Synthetic fusion cytokine, GIFT4, transduced autologous peritoneal immune cells - a novel cell therapy for the treatment of ovarian cancer
Journal Articles

Abstract 902: Augmentation of anti-melanoma response by combining radiation-based in situ vaccination with GIFT4 B cell therapy

Elizabeth G. Sumiec, Claire C. Baniel, Amber M. Bates, Sarah Emma, Erin Nystuen, Alexander L. Rakhmilevich, Amy K. Erbe, Pradyut Paul, Jacques Galipeau, Paul M. Sondel, Zachary S. Morris
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 902.
https://doi.org/10.1158/1538-7445.AM2020-902
Published: 15 August 2020
View articletitled, Abstract 902: Augmentation of anti-melanoma response by combining radiation-based in situ vaccination with GIFT4 B cell therapy
Journal Articles

Abstract B24: A multicellular, microfluidic model of the human bone marrow niche in metastatic cancers

Nan Sethakorn, David Kosoff, Erika Heninger, Jasmine Martinez Soto, Jiaquan Yu, Rahul Das, David Jarrard, Jacques Galipeau, Peiman Hematti, Scott Dehm, David J. Beebe, Joshua M. Lang
Journal: Cancer Research
Cancer Res (2020) 80 (11_Supplement): B24.
https://doi.org/10.1158/1538-7445.CAMODELS2020-B24
Published: 02 June 2020
View articletitled, Abstract B24: A multicellular, microfluidic model of the human bone marrow niche in metastatic cancers
Journal Articles

Stimulation of Natural Killer Cell–Mediated Tumor Immunity by an IL15/TGFβ–Neutralizing Fusion Protein

Spencer Ng, Jiusheng Deng, Raghavan Chinnadurai, Shala Yuan, Andrea Pennati, Jacques Galipeau
Journal: Cancer Research
Cancer Res (2016) 76 (19): 5683–5695.
https://doi.org/10.1158/0008-5472.CAN-16-0386
Published: 02 October 2016
View articletitled, Stimulation of Natural Killer Cell–Mediated Tumor Immunity by an IL15/TGFβ–Neutralizing Fusion Protein
Open the PDF for Stimulation of Natural Killer Cell–Mediated Tumor Immunity by an IL15/TGFβ–Neutralizing Fusion Protein in another window
Includes: Supplementary data
Journal Articles

Engineered Fusokine GIFT4 Licenses the Ability of B Cells to Trigger a Tumoricidal T-cell Response

Jiusheng Deng, Shala Yuan, Andrea Pennati, Jordan Murphy, Jian Hui Wu, David Lawson, Jacques Galipeau
Journal: Cancer Research
Cancer Res (2014) 74 (15): 4133–4144.
https://doi.org/10.1158/0008-5472.CAN-14-0708
Published: 31 July 2014
View articletitled, Engineered Fusokine GIFT4 Licenses the Ability of B Cells to Trigger a Tumoricidal T-cell Response
Open the PDF for Engineered Fusokine GIFT4 Licenses the Ability of B Cells to Trigger a Tumoricidal T-cell Response in another window
Includes: Supplementary data
Journal Articles

B Effector Cells Activated by a Chimeric Protein Consisting of IL-2 and the Ectodomain of TGF-β Receptor II Induce Potent Antitumor Immunity

Claudia Penafuerte, Spencer Ng, Norma Bautista-Lopez, Elena Birman, Kathy Forner, Jacques Galipeau
Journal: Cancer Research
Cancer Res (2012) 72 (5): 1210–1220.
https://doi.org/10.1158/0008-5472.CAN-11-1659
Published: 01 March 2012
View articletitled, B Effector Cells Activated by a Chimeric Protein Consisting of IL-2 and the Ectodomain of TGF-β Receptor II Induce Potent Antitumor Immunity
Open the PDF for B Effector Cells Activated by a Chimeric Protein Consisting of IL-2 and the Ectodomain of TGF-β Receptor II Induce Potent Antitumor Immunity in another window
Includes: Supplementary data
Journal Articles

Abstract 1793: 5-Fluorouracil chemotherapy acts synergistically with adoptive dendritic cell immunotherapy to induce durable anti-tumor responses in vivo

Patrick Williams, Manaf Bouchentouf, Moutih Rafei, Raphaelle Romieu-Mourez, Shala Yuan, Kathy A. Forner, Elena Birman, Jacques Galipeau
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 1793.
https://doi.org/10.1158/1538-7445.AM2011-1793
Published: 15 April 2011
View articletitled, Abstract 1793: 5-Fluorouracil chemotherapy acts synergistically with adoptive dendritic cell immunotherapy to induce durable anti-tumor responses in vivo
Journal Articles

Mesenchymal Stromal Cells Expressing ErbB-2/neu Elicit Protective Antibreast Tumor Immunity In vivo, Which Is Paradoxically Suppressed by IFN-γ and Tumor Necrosis Factor-α Priming

Raphaëlle Romieu-Mourez, Moïra François, Amanda Abate, Marie-Noëlle Boivin, Elena Birman, Dana Bailey, Jonathan L. Bramson, Kathy Forner, Yoon-Kow Young, Jeffrey A. Medin, Jacques Galipeau
Journal: Cancer Research
Cancer Res (2010) 70 (20): 7742–7747.
https://doi.org/10.1158/0008-5472.CAN-10-0296
Published: 13 October 2010
View articletitled, Mesenchymal Stromal Cells Expressing ErbB-2/neu Elicit Protective Antibreast Tumor Immunity In vivo, Which Is Paradoxically Suppressed by IFN-γ and Tumor Necrosis Factor-α Priming
Open the PDF for Mesenchymal Stromal Cells Expressing ErbB-2/neu Elicit Protective Antibreast Tumor Immunity In vivo, Which Is Paradoxically Suppressed by IFN-γ and Tumor Necrosis Factor-α Priming in another window
Journal Articles

The Human Ortholog of Granulocyte Macrophage Colony-Stimulating Factor and Interleukin-2 Fusion Protein Induces Potent Ex vivo Natural Killer Cell Activation and Maturation

Claudia Penafuerte, Norma Bautista-Lopez, Boulassel Mohamed-Rachid, Jean-Pierre Routy, Jacques Galipeau
Journal: Cancer Research
Cancer Res (2009) 69 (23): 9020–9028.
https://doi.org/10.1158/0008-5472.CAN-09-2322
Published: 30 November 2009
View articletitled, The Human Ortholog of Granulocyte Macrophage Colony-Stimulating Factor and Interleukin-2 Fusion Protein Induces Potent Ex vivo Natural Killer Cell Activation and Maturation
Open the PDF for The Human Ortholog of Granulocyte Macrophage Colony-Stimulating Factor and Interleukin-2 Fusion Protein Induces Potent Ex vivo Natural Killer Cell Activation and Maturation in another window
Includes: Supplementary data
Journal Articles

Neo-Organoid of Marrow Mesenchymal Stromal Cells Secreting Interleukin-12 for Breast Cancer Therapy

Nicoletta Eliopoulos, Moïra Francois, Marie-Noëlle Boivin, Daniel Martineau, Jacques Galipeau
Journal: Cancer Research
Cancer Res (2008) 68 (12): 4810–4818.
https://doi.org/10.1158/0008-5472.CAN-08-0160
Published: 16 June 2008
View articletitled, Neo-Organoid of Marrow Mesenchymal Stromal Cells Secreting Interleukin-12 for Breast Cancer Therapy
Open the PDF for Neo-Organoid of Marrow Mesenchymal Stromal Cells Secreting Interleukin-12 for Breast Cancer Therapy in another window
Journal Articles

Plasminogen Kringle 5–Engineered Glioma Cells Block Migration of Tumor-Associated Macrophages and Suppress Tumor Vascularization and Progression

Sabrina R. Perri, Josephine Nalbantoglu, Borhane Annabi, Zafiro Koty, Laurence Lejeune, Moïra François, Marcos R. Di Falco, Richard Béliveau, Jacques Galipeau
Journal: Cancer Research
Cancer Res (2005) 65 (18): 8359–8365.
https://doi.org/10.1158/0008-5472.CAN-05-0508
Published: 15 September 2005
View articletitled, Plasminogen Kringle 5–Engineered Glioma Cells Block Migration of Tumor-Associated Macrophages and Suppress Tumor Vascularization and Progression
Open the PDF for Plasminogen Kringle 5–Engineered Glioma Cells Block Migration of Tumor-Associated Macrophages and Suppress Tumor Vascularization and Progression in another window
Journal Articles

Soluble human plasminogen kringle 5 domain acts as a 2-pronged anti-cancer agent inhibiting both endothelial cells and tumor-associated macrophages

Sabrina R. Perri, Borhane Annabi, Laurence Lejeune, Moöra François, Richard Béliveau, Jacques Galipeau
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 708.
Published: 01 May 2005
View articletitled, Soluble human plasminogen kringle 5 domain acts as a 2-pronged anti-cancer agent inhibiting both endothelial cells and tumor-associated macrophages
Journal Articles

Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-2 Fusion cDNA for Cancer Gene Immunotherapy

John Stagg, Jian Hui Wu, Nathaniel Bouganim, Jacques Galipeau
Journal: Cancer Research
Cancer Res (2004) 64 (24): 8795–8799.
https://doi.org/10.1158/0008-5472.CAN-04-1776
Published: 16 December 2004
View articletitled, Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-2 Fusion cDNA for Cancer Gene Immunotherapy
Open the PDF for Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-2 Fusion cDNA for Cancer Gene Immunotherapy in another window
Journal Articles

Loss of Tumorigenicity and Metastatic Potential in Carcinoma Cells Expressing the Extracellular Domain of the Type 1 Insulin-Like Growth Factor Receptor

Amir Abbas Samani, Eric Chevet, Lucia Fallavollita, Jacques Galipeau, Pnina Brodt
Journal: Cancer Research
Cancer Res (2004) 64 (10): 3380–3385.
https://doi.org/10.1158/0008-5472.CAN-03-3780
Published: 17 May 2004
View articletitled, Loss of Tumorigenicity and Metastatic Potential in Carcinoma Cells Expressing the Extracellular Domain of the Type 1 Insulin-Like Growth Factor Receptor
Open the PDF for Loss of Tumorigenicity and Metastatic Potential in Carcinoma Cells Expressing the Extracellular Domain of the Type 1 Insulin-Like Growth Factor Receptor in another window
Journal Articles

In Vivo Interferon Regulatory Factor 3 Tumor Suppressor Activity in B16 Melanoma Tumors

Delphine Duguay, François Mercier, John Stagg, Daniel Martineau, Jonathan Bramson, Marc Servant, Rongtuan Lin, Jacques Galipeau, John Hiscott
Journal: Cancer Research
Cancer Res (2002) 62 (18): 5148–5152.
Published: 15 September 2002
View articletitled, In Vivo Interferon Regulatory Factor 3 Tumor Suppressor Activity in B16 Melanoma Tumors
Open the PDF for In Vivo Interferon Regulatory Factor 3 Tumor Suppressor Activity in B16 Melanoma Tumors in another window
Journal Articles

Vesicular Stomatitis Virus G Pseudotyped Retrovector Mediates Effective in Vivo Suicide Gene Delivery in Experimental Brain Cancer

Jacques Galipeau, Hewei Li, André Paquin, Franca Sicilia, George Karpati, Josephine Nalbantoglu
Journal: Cancer Research
Cancer Res (1999) 59 (10): 2384–2394.
Published: 15 May 1999
View articletitled, Vesicular Stomatitis Virus G Pseudotyped Retrovector Mediates Effective in Vivo Suicide Gene Delivery in Experimental Brain Cancer
Open the PDF for Vesicular Stomatitis Virus G Pseudotyped Retrovector Mediates Effective in Vivo Suicide Gene Delivery in Experimental Brain Cancer in another window